Stock Track | Oscar Health Plummets 6.79% in Pre-market on Revenue Miss and House Subpoena
Stock Track
Feb 10
Oscar Health's stock plunged 6.79% in pre-market trading on Tuesday, following two significant negative developments that weighed on investor sentiment.
The health insurer reported fourth-quarter revenue of $2,805.235 million, which fell short of the Ibes estimate of $3,124 million. This revenue miss indicates weaker-than-expected financial performance for the quarter.
Additionally, Oscar Health was among eight Affordable Care Act health insurers subpoenaed by Republican House Judiciary Chair Jim Jordan as part of a widening investigation into potential fraud surrounding the use of premium subsidies. The regulatory scrutiny adds uncertainty and potential legal risks for the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.